Holding(s) in Company
Tracarta Ltd, through Fiske Nominees Limited, has acquired a significant stake in Futura Medical Plc, crossing a notification threshold on September 25, 2026. The notification reveals that Tracarta Ltd now holds 3.96% of voting rights attached to shares and an additional 0.34% through financial instruments, specifically warrants with an expiration date of September 25, 2031, resulting in a total holding of 4.3% of voting rights. This acquisition represents a change in the breakdown of voting rights for Futura Medical Plc.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
| An acquisition or disposal of voting rights | X |
| An acquisition or disposal of financial instruments | X |
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | Tracarta Ltd |
Full name of shareholder(s) (if different from 3.) v
| Name | Fiske Nominees Limited |
| City and country of registered office (if applicable) | 100 Wood Street, London, England, EC2V 7AN |
| 5. Date on which the threshold was crossed or reached vi : | 25/09/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 30/09/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 3.96% | 0.34% | 4.3% | 63,750,000 |
| Position of previous notification (if applicable) | 3.96% | 0.00% | 4.3% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB0033278473 | 58,750,000 | 3.96% | ||
| SUBTOTAL 8. A | 58,750,000 | 3.96% | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Warrant | 25/09/2031 | 5 Years from issue | 5,000,000 | 0.34% |
| SUBTOTAL 8. B 1 | 5,000,000 | 0.34% | ||
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Dr John Wardle (shareholder of Tracarta Limited) | - | - | - |
| Tracarta Limited | 4.3% | - | 4.3% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | Guernsey |
| Date of completion | 30/09/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.